Viewing Study NCT02685267


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-05-05 @ 9:44 AM
Study NCT ID: NCT02685267
Status: TERMINATED
Last Update Posted: 2021-04-09
First Post: 2016-02-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
Sponsor:
Organization: